Form 8-K - Current report:
SEC Accession No. 0001213900-24-112658
Filing Date
2024-12-26
Accepted
2024-12-26 16:05:37
Documents
13
Period of Report
2024-12-22
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea022580301-8k_chinapharma.htm   iXBRL 8-K 38670
  Complete submission text file 0001213900-24-112658.txt   215365

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cphi-20241222.xsd EX-101.SCH 3048
3 XBRL LABEL FILE cphi-20241222_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cphi-20241222_pre.xml EX-101.PRE 22381
15 EXTRACTED XBRL INSTANCE DOCUMENT ea022580301-8k_chinapharma_htm.xml XML 3783
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 241581071
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)